4D pharma: Update on Suspension of Trading

(marketscreener.com) 4D pharma plc , a pharmaceutical company leading the development of Live Biotherapeutic products , a novel class of drug derived from the microbiome, provides an update to the announcement released earlier today regarding the Company's request for an immediate suspension of trading in the Company's ordinary shares on AIM which took...https://www.marketscreener.com/quote/stock/4D-PHARMA-PLC-56171591/news/Update-on-Suspension-of-Trading-40810241/?utm_medium=RSS&utm_content=20220624